JACC. Case reports · 2026
Minimum-Radiation Percutaneous Coronary Intervention for Pregnant Woman With Acute Coronary Syndrome.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gasys Antanas, Kakizaki Ryota, Raio Luigi, Räber Lorenz
Аннотация
BACKGROUND: Acute coronary syndrome during pregnancy is rare with limited evidence; management must be tailored to safeguard both mother and fetus.
CASE SUMMARY: A 40-year-old woman with type 2 diabetes presented with acute coronary syndrome at 11+3 weeks' gestation. She underwent intracoronary imaging-guided percutaneous coronary intervention (PCI) (3.0- × 28-mm stent, mean external elastic lamina diameter: 3.07 mm, lesion length: 28 mm) under minimal radiation (estimated fetal dose: ≈0.00004 mGy). After optimal stent implantation, 6 weeks of dual antiplatelet therapy with aspirin and clopidogrel were followed by lifelong aspirin. Pregnancy was uncomplicated with healthy infant delivered at 39 weeks. Postpartum angiography confirmed good result, and statin was initiated.
DISCUSSION: Intracoronary imaging-guided PCI enables precise diagnosis and tailored therapy with reduced radiation exposure. Drug regimens balance maternal benefit and fetal safety.
TAKE-HOME MESSAGES: Intracoronary imaging-guided PCI allows precise and safe treatment in pregnant ACS patients. Drug therapy must be adapted to avoid fetal risk while ensuring maternal protection.
CASE SUMMARY: A 40-year-old woman with type 2 diabetes presented with acute coronary syndrome at 11+3 weeks' gestation. She underwent intracoronary imaging-guided percutaneous coronary intervention (PCI) (3.0- × 28-mm stent, mean external elastic lamina diameter: 3.07 mm, lesion length: 28 mm) under minimal radiation (estimated fetal dose: ≈0.00004 mGy). After optimal stent implantation, 6 weeks of dual antiplatelet therapy with aspirin and clopidogrel were followed by lifelong aspirin. Pregnancy was uncomplicated with healthy infant delivered at 39 weeks. Postpartum angiography confirmed good result, and statin was initiated.
DISCUSSION: Intracoronary imaging-guided PCI enables precise diagnosis and tailored therapy with reduced radiation exposure. Drug regimens balance maternal benefit and fetal safety.
TAKE-HOME MESSAGES: Intracoronary imaging-guided PCI allows precise and safe treatment in pregnant ACS patients. Drug therapy must be adapted to avoid fetal risk while ensuring maternal protection.